Clusterin and Related Scoring Index as Potential Early Predictors of Response to Sorafenib in Hepato...
Clusterin and Related Scoring Index as Potential Early Predictors of Response to Sorafenib in Hepatocellular Carcinoma
About this item
Full title
Author / Creator
Narahara, Satoshi , Watanabe, Takehisa , Nagaoka, Katsuya , Fujimoto, Nahoko , Furuta, Yoki , Tanaka, Kentaro , Tokunaga, Takayuki , Kawasaki, Takeshi , Yoshimaru, Yoko , Setoyama, Hiroko , Oniki, Kentaro , Saruwatari, Junji , Tateyama, Masakuni , Naoe, Hideaki , Tanaka, Motohiko , Tanaka, Yasuhito and Sasaki, Yutaka
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Advanced hepatocellular carcinoma (HCC) remains a highly lethal malignancy, although several systemic therapeutic options are available, including sorafenib (SFN), which has been one of the standard treatment agents for almost a decade. As early prediction of response to SFN remains challenging, biomarkers that enable early prediction using a clini...
Alternative Titles
Full title
Clusterin and Related Scoring Index as Potential Early Predictors of Response to Sorafenib in Hepatocellular Carcinoma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_45aa45a8d48f45b7b7adf065cdba44de
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_45aa45a8d48f45b7b7adf065cdba44de
Other Identifiers
ISSN
2471-254X
E-ISSN
2471-254X
DOI
10.1002/hep4.1872
